Related Experiment Video
Updated: Aug 7, 2026

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells
Published on: August 19, 2016
Trigger for group A streptococcal M1T1 invasive disease
Jason N Cole1, Jason D McArthur, Fiona C McKay
1School of Biological Sciences, University of Wollongong, Wollongong, New South Wales, 2522, Australia.
Abstract:
The globally disseminated Streptococcus pyogenes M1T1 clone causes a number of highly invasive human diseases. The transition from local to systemic infection occurs by an unknown mechanism; however invasive M1T1 clinical isolates are known to express significantly less cysteine protease SpeB than M1T1 isolates from local infections. Here, we show that in comparison to the M1T1 strain 5448, the isogenic mutant delta speB accumulated 75-fold more human plasmin activity on the bacterial surface following incubation in human plasma. Human plasminogen was an absolute requirement for M1T1 strain 5448 virulence following subcutaneous (s.c.) infection of humanized plasminogen transgenic mice. S. pyogenes M1T1 isolates from the blood of infected humanized plasminogen transgenic mice expressed reduced levels of SpeB in comparison with the parental 5448 used as inoculum. We propose that the human plasminogen system plays a critical role in group A streptococcal M1T1 systemic disease initiation. SpeB is required for S. pyogenes M1T1 survival at the site of local infection, however, SpeB also disrupts the interaction of S. pyogenes M1T1 with the human plasminogen activation system. Loss of SpeB activity in a subpopulation of S. pyogenes M1T1 at the site of infection results in accumulation of surface plasmin activity thus triggering systemic spread.
Insights
Group A Streptococcus M1T1 bacteria spread systemically by hijacking the human plasminogen system. Reduced SpeB protease activity allows M1T1 bacteria to accumulate plasmin, initiating invasive disease.
Area of Science:
- Microbiology
- Infectious Diseases
- Molecular Biology
Background:
- The globally prevalent Streptococcus pyogenes M1T1 clone causes severe invasive human diseases.
- The mechanism of transition from localized infection to systemic disease remains unclear.
- Invasive M1T1 isolates exhibit lower cysteine protease SpeB expression than those from localized infections.
Purpose of the Study:
- To investigate the role of the human plasminogen system in Streptococcus pyogenes M1T1 systemic infection.
- To elucidate the function of SpeB protease in M1T1 pathogenesis and dissemination.
Main Methods:
- Comparison of wild-type M1T1 strain 5448 with an isogenic delta speB mutant.
- Incubation in human plasma to assess surface plasmin activity.
- Infection of humanized plasminogen transgenic mice to evaluate virulence and SpeB expression.
Main Results:
- The delta speB mutant accumulated 75-fold more human plasmin activity on its surface compared to the wild-type strain.
- Human plasminogen was essential for M1T1 virulence in vivo.
- M1T1 isolates from systemic infections showed reduced SpeB levels.
Conclusions:
- The human plasminogen system is critical for initiating Streptococcus pyogenes M1T1 systemic disease.
- SpeB protease is necessary for M1T1 survival at the infection site but hinders plasminogen interaction.
- Loss of SpeB in a bacterial subpopulation facilitates plasmin accumulation and systemic spread.
Related Concept Videos
Streptococcal Pharyngitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis
Determinants of Bacterial Pathogenicity and Virulence
Bacterial Meningitis II: Pathophysiology
Clinical Significance of Antibiotic Resistance